4.10.26.1Vertical

Adult Neurological Speech Rehabilitation

SLP programs treating aphasia, dysphagia, and communication disorders in stroke and TBI patients.

Market snapshot

These figures describe Speech-Language Pathology (4.10.26), the segment that Adult Neurological Speech Rehabilitation sits within. They are not figures for Adult Neurological Speech Rehabilitation on its own.

FragmentationConsolidatingEstimate

Within therapy offices (NAICS 621340) and pediatric services; the Census Bureau does not separate speech-language pathology, so the segment is not separately sized.

Business model & economics

Revenue model

Per-visit and per-session therapy reimbursement

Key economics

Recurring revenue
High

recurring multi-visit therapy

EBITDA margin
12–22%
Capex intensity
Low

Characteristics

  • Pediatric speech therapy an active roll-up area.
  • Rising identification of pediatric needs.
  • SLP shortage constrains supply.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Pediatric multi-therapy platforms
  • PE-backed therapy consolidators
  • Rehabilitation acquirers

What’s driving deals

  • Pediatric multi-therapy roll-up.
  • Rising pediatric-needs identification.
  • SLP workforce constraints.

Find Adult Neurological Speech Rehabilitation acquisition targets

Search Acquisera’s index for companies classified under Adult Neurological Speech Rehabilitation (4.10.26.1) and build a targeted deal pipeline.

Search companies